# A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years

> **NCT00079105** · PHASE2 · COMPLETED · sponsor: **Newcastle-upon-Tyne Hospitals NHS Trust** · enrollment: 175 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** bleomycin sulfate
- **DRUG:** cyclophosphamide
- **DRUG:** etoposide
- **DRUG:** mitoxantrone hydrochloride
- **DRUG:** prednisolone
- **DRUG:** procarbazine hydrochloride
- **DRUG:** vinblastine sulfate

## Key facts

- **NCT ID:** NCT00079105
- **Lead sponsor:** Newcastle-upon-Tyne Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2017-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00079105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00079105, "A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00079105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*